Free Signup

OASIS® Wound Matrix

Smith & Nephew, Inc.

OASIS Wound Matrix is a naturally derived structure that helps support the body's own wound closure mechanisms
OASIS Wound Matrix is an intact matrix naturally derived from porcine small intestinal submucosa (SIS), indicated for the management of wounds

  • 8213100033: OASIS® Wound Matrix 3 x 3.5 cm fenestrated, 10 Sheets in box: Q4102
  • 8213100037: OASIS® Wound Matrix 3 x 7 cm fenestrated, 10 Sheets in box: Q4102

* The product information contained on this page, including the product images and additional product materials, was collected from various supplier sources. All product claims and specifications are those of the product suppliers. Every effort has been made to ensure the accuracy of the product information, however on occasion manufacturers may alter their products or packaging without notice. Wound Reference assumes no liability for inaccuracies or misstatements about products. The properties of a product may change or be inaccurate following the posting or printing of the product information in the document, either in the print or online version. Due to product changes, information listed in this document is subject to change without notice. We recommend that you always read labels, warnings and instructions for use before using a product. Content on this site is for reference purposes and is not intended to be a substitute for professional advice given by a physician or other licensed healthcare professional.

ESSENTIALS

Product
Rating
Suppliers Price
HCPCS Class
HCPCS
Oasis wound matrix, per square centimeter
Q4102
* Hover on the information button next to each header for detailed explanation on the type of information provided by the table
Choose the state for Medicare
DME coverage and co-payment
Manufacturer
Product
Rating
Suppliers Price
Patient DME Co-Payment per Billable Unit
DME Reimbursement to Suppliers
Frequency Replacement if Requirements Met
Office and/or Facility - Product reimbursement
$.00
per square centimeter (non-DMEPOS)
See Coding, Coverage and Reimbursement
$11.01
* Every effort has been made to ensure the accuracy of the product information, however you should visit the manufacturer's website for the latest information.
* Hover on the information button next to each header for detailed explanation on the type of information provided by the table
Product
Rating
Suppliers Price
Recom / Evidence
FDA Safety
Quality Measures
Cost Effectiveness
Product
Rating
Suppliers Price
Features
Composition: Animal-derived Configuration: Sheet May apply on full-thickness wounds Shelf life: Greater than 2 years Storage: room temp
CPT CodeDescription Physician Reimbursement - Office Physician Reimbursement - Facility Facility Reimbursement
C5271Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area
C5273Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children
C5274Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)
C5275Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area
C5272Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure)
C5276Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure)
C5277Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children
C5278Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately with primary procedure)
  • Based on national averages
  • Medicare payments for participating qualified health professionals (QHP) for services performed in their Offices (*) or at a Facility (** i.e., hospital outpatient department or ambulatory service center). Payments are nationally unadjusted average amounts, and do not account for differences in payment due to geographic variation. The allowed rate for non-participating physicians is set at 95% of the allowable for participating physicians. Non-participating physicians are subject to the limiting charge rules. The coinsurance is limited to 20% of the allowable fee.
  • When covered by the Medicare contractor, this manufacturer product is separately payable in a QHP office based on the Average Sales Price (ASP) as reported by the manufacturer on a quarterly basis.
  • Hover on the information button next to each header for detailed explanation on the type of information provided by the table
  • The information provided on this website is informational only. This is not a guarantee of Reimbursement Rates, nor is it intended to make recommendations regarding clinical practices. Information on this website is subject to change with out notice due to changes in reimbursement laws, regulations, rules and policies. The ultimate responsibility for correct coding lies with the provider of services. Please contact the appropriate payer for their interpretation of the appropriate code to use for the procedure.
  • CPT® is a registered trademark of the American Medical Association. All CPT codes and descriptions are copyrighted 2018, American Medical Association. All rights reserved. CPT codes and CPT descriptions are from the current manuals and those included herein are not intended to be all-inclusive and are included for informational purposes only. Codes referenced on Wound Reference are for informational purposes only. Inclusion or exclusion of any codes does not guarantee coverage. Providers should reference the American Medical Association prior to the submission of claims for reimbursement of covered services.

CLINICAL

Indications

 It is indicated “for the management of wounds including: partial and full-thickness wounds; pressure ulcers; venous ulcers; diabetic ulcers; chronic vascular ulcers; tunneled, undermined wounds; surgical wounds (donor sites/grafts, post-Mohs surgery, post-laser surgery, podiatric, wound dehiscence); trauma wounds (abrasions, lacerations, second-degree burns, and skin tears); draining wounds.

FDA

Cleared for marketing under the 510(k) process in July 2006 (K061711) and is intended for one-time use.” Oasis is included in FDA product code KGN (dressing, wound, collagen)

CONTRAINDICATIONS

This device is derived from a porcine source and should not be used in patients with known sensitivity to porcine material. This device is not indicated for use in third degree burns.

PRECAUTIONS:

• Do not re-sterilize. Discard all open and unused portions of OASIS® Wound Matrix.

• Device is sterile if the package is dry, unopened and undamaged. Do not use if the package seal is broken.

• The device must be used prior to the expiration date.

• Discard device if mishandling has caused possible damage or contamination.

• OASIS® Wound Matrix should not be applied until excessive exudate, bleeding, acute swelling, and infection is controlled.

POTENTIAL COMPLICATIONS:

The following complications are possible. If any of these conditions occur, the device should be removed.

• Infection

• Chronic inflammation (Initial application of wound dressings may be associated with transient, mild, localized inflammation.)

• Allergic reaction

• Excessive redness, pain, swelling, or blistering

STORAGE:

This device should be stored in a clean, dry location at room temperature.

STERILIZATION:

This device has been sterilized with ethylene oxide.

SUGGESTED INSTRUCTIONS FOR USING OASIS® WOUND MATRIX

NOTE: Always handle OASIS® Wound Matrix using aseptic technique.

I. Wound Bed Preparation

A. Prepare the wound bed using standard methods to ensure it is free of exudate and devitalized tissue. An initial excision or debridement of the wound may be necessary to ensure the wound edges contain viable tissue.

B. Wait for any bleeding to stop before applying OASIS® Wound Matrix.

C. Cleanse the wound thoroughly with sterile saline.

II. Selection and Preparation of OASIS® Wound Matrix

A. Measure the wound and select the appropriate size sheet of dry OASIS® Wound Matrix. If necessary, the product may be additionally fenestrated or meshed with a scalpel.

B. Cut the sheet to a size and shape that will cover the entire wound surface and will extend slightly beyond the wound margins.

III. Application of OASIS® Wound Matrix

A. For ease of handling, apply OASIS® Wound Matrix by placing it in a dry state over the wound.

B. Position the dry OASIS® Wound Matrix to completely contact the entire surface of the wound bed and extend slightly beyond all wound margins. If multiple sheets are necessary to cover the wound, slightly overlap the edges of the sheets.

C. As required, securely anchor OASIS® Wound Matrix with physician’s preferred fixation method (e.g., STERI-STRIPTM, tissue sealant, bolsters, dissolvable clips, sutures, staples, or other appropriate fixation method) based on the type of wound, location of wound, patient’s mobility, and patient compliance.

D. Thoroughly rehydrate OASIS® Wound Matrix by applying sterile saline.

E. To protect OASIS® Wound Matrix from adhering to the secondary dressing, apply an appropriate nonadherent primary wound dressing over the OASIS® Wound Matrix.

F. Apply an appropriate secondary dressing (multi-layer compression bandage system, total contact cast, or other appropriate dressing) that will manage the wound exudate, keep the OASIS® Wound Matrix moist, and keep all layers securely in place.

IV. Dressing Changes

A. To prevent damage to the newly incorporating OASIS® Wound Matrix, only change the primary dressing as necessary, typically every 7 days.

B. Change the secondary dressing as appropriate. Take care to avoid dislodging the OASIS® Wound Matrix when the secondary dressing is changed.

V. Wound Assessment and Wound Bed Preparation for Reapplication of OASIS® Wound Matrix

A. Change all dressings every 7 days, or as necessary.

NOTE: If a gel forms on the wound surface, do not attempt to forcibly remove it. Successful absorption of OASIS® Wound Matrix may form a caramel-colored or off white gel. Do not remove this gel by debridement. This caramelization contains extracellular matrix (ECM), which

continues to replace deficient and missing ECM in the wound.

B. As healing occurs, sections of OASIS® Wound Matrix may gradually peel. Carefully remove any remaining loose products around the edge as needed.

C. Gently cleanse the wound surface with sterile saline; leave the ECM gel intact.

D. Carefully reassess the wound and record healing progression such as wound dimensions, wound depth, wound type, and other relevant information.

VI. Reapplication of OASIS® Wound Matrix and Dressing Changes

A. Change secondary dressings as needed (see step IV).

B. If the wound is free of infection and necrosis but not fully epithelialized, reapply newly prepared OASIS® Wound Matrix over previously absorbed application (see steps II and III).

C. Reapply OASIS® Wound Matrix every 7 days or as needed by repeating previous application steps.

NOTE: If excess exudate collects under the sheet, small openings can be cut in the sheet to allow the exudate to drain.

http://www.oasiswoundmatrix.com/sites/default/files/resources/oasis_owm_instructions_for_use.pdf

CODING, COVERAGE AND REIMBURSEMENT

This section currently focuses primarily on Medicare. It may be expanded in the future to include information on private insurers as well. 

Frequency of replacement allowed by Medicare:



Medicare Administrative Contractor (MAC)Frequency of replacement if requirements met
Novitas Solutions, Inc.10 units in 12 weeks
CGS Administrators, LLC10 units in 12 weeks
Palmetto10 units in 12 weeks
First Coast Service Options, Inc. (FCSO)

1 type of product per 12 weeks, fewest repeat applications and amount of product is expected

Noridian

Wisconsin Physicians Service Insurance Corporation (WPS)

National Government Services, Inc. (NGS)

Carrier discretion

More details on requirements, medical necessity and documentation in specific Medicare Local Coverage Determinations (if available). See section on Coding, Coverage and Reimbursement in topic "Cellular and/or Tissue Products". 





Official reprint from WoundReference® woundreference.com ©2018 Wound Reference, Inc. All Rights Reserved